首页 > 最新文献

Indian Journal of Medical Microbiology最新文献

英文 中文
Unveiling the microbiological experience in exploring spinal TB cases from a tertiary care center 揭示微生物的经验,探索脊柱结核病例从三级保健中心。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-16 DOI: 10.1016/j.ijmmb.2026.101050
Jaya Biswas , Kiran Bala , Neha Nityadarshini , Leander Jose , Vivek Shankar , Urvashi B. Singh

Purpose

Spinal tuberculosis, a severe form of extrapulmonary tuberculosis, poses significant diagnostic and therapeutic challenges, often leading to neurological complications and deformity. Microbiological confirmation is crucial for diagnosis and effective treatment. We aim to evaluate the microbiological profile and diagnostic yield of various methods in spinal TB cases at a tertiary care centre and to correlate with clinical features and treatment outcomes.

Methods

A prospective study was conducted on samples from patients with suspected spinal TB (n = 58) from July 2023 to September 2024. All samples were processed using Ziehl-Neelsen (ZN) staining for acid-fast bacilli (AFB), culture on Lowenstein-Jensen (LJ) medium, BACTEC MGIT 960 liquid culture system, and GeneXpert MTB/RIF assay for rapid detection of MTB and rifampicin sensitivity. Relevant demographic, clinical, and radiological data were collected and analyzed. Based on susceptibility to drugs of culture isolates, treatment was started to see the outcome, and follow-ups were done with the patients.

Results

A total of 19 spinal TB cases were microbiologically confirmed, out of 58 clinically suspected spinal TB cases, with a male predominance (57.9 %) and age range of 13–72 years. The most common symptom was lower back pain (89.5 %). GeneXpert was positive in all cases, detecting rifampicin resistance in 7(36.8 %). Culture was positive in 11 cases. ZN staining was positive in 15.8 % of direct samples. Histopathology showed granulomatous inflammation in 9 (47.3 %) of cases. MRI confirmed infective spinal involvement in 17(89.5 %) patients. MDR-TB regimen was initiated in 7 patients. Overall recovery was good, except one case of neuropathy and one mortality.

Conclusions

A combination of smear microscopy, culture, and molecular diagnostics significantly improves the microbiological diagnosis of spinal TB. GeneXpert offers rapid, reliable results, especially in rifampicin resistance detection. Early and accurate microbiological confirmation, coupled with clinical-radiological correlation, is essential for effective management and improved patient outcomes.
目的:脊柱结核是肺外结核的一种严重形式,对诊断和治疗提出了重大挑战,通常导致神经系统并发症和畸形。微生物学确认对诊断和有效治疗至关重要。我们的目的是评估在三级保健中心的脊柱结核病例中各种方法的微生物谱和诊断产量,并与临床特征和治疗结果相关联。方法:对2023年7月至2024年9月期间疑似脊柱结核患者(n=58)进行前瞻性研究。所有样品均采用Ziehl-Neelsen (ZN)染色法检测抗酸杆菌(AFB), Lowenstein-Jensen (LJ)培养基培养,BACTEC MGIT 960液体培养系统,GeneXpert MTB/RIF法快速检测MTB和利福平敏感性。收集并分析了相关的人口学、临床和放射学资料。根据培养分离菌对药物的敏感性,开始治疗,并对患者进行随访。结果:58例脊柱结核临床疑似病例中,微生物学确诊19例,男性居多(57.9%),年龄13 ~ 72岁。最常见的症状是腰痛(89.5%)。GeneXpert检测结果均为阳性,其中7例(36.8%)检测出利福平耐药。11例培养阳性。15.8%的直接样品ZN染色阳性。组织病理学检查显示肉芽肿性炎症9例(47.3%)。MRI证实17例(89.5%)患者有感染性脊柱受累。7名患者开始了耐多药结核病治疗方案。除1例神经病变和1例死亡外,整体恢复良好。结论:涂片镜检、培养和分子诊断相结合可显著提高脊柱结核的微生物学诊断。GeneXpert提供快速、可靠的结果,特别是在利福平耐药性检测方面。早期和准确的微生物学确认,加上临床-放射学相关性,对于有效管理和改善患者预后至关重要。
{"title":"Unveiling the microbiological experience in exploring spinal TB cases from a tertiary care center","authors":"Jaya Biswas ,&nbsp;Kiran Bala ,&nbsp;Neha Nityadarshini ,&nbsp;Leander Jose ,&nbsp;Vivek Shankar ,&nbsp;Urvashi B. Singh","doi":"10.1016/j.ijmmb.2026.101050","DOIUrl":"10.1016/j.ijmmb.2026.101050","url":null,"abstract":"<div><h3>Purpose</h3><div>Spinal tuberculosis, a severe form of extrapulmonary tuberculosis, poses significant diagnostic and therapeutic challenges, often leading to neurological complications and deformity. Microbiological confirmation is crucial for diagnosis and effective treatment. We aim to evaluate the microbiological profile and diagnostic yield of various methods in spinal TB cases at a tertiary care centre and to correlate with clinical features and treatment outcomes.</div></div><div><h3>Methods</h3><div>A prospective study was conducted on samples from patients with suspected spinal TB (n = 58) from July 2023 to September 2024. All samples were processed using Ziehl-Neelsen (ZN) staining for acid-fast bacilli (AFB), culture on Lowenstein-Jensen (LJ) medium, BACTEC MGIT 960 liquid culture system, and GeneXpert MTB/RIF assay for rapid detection of MTB and rifampicin sensitivity. Relevant demographic, clinical, and radiological data were collected and analyzed. Based on susceptibility to drugs of culture isolates, treatment was started to see the outcome, and follow-ups were done with the patients.</div></div><div><h3>Results</h3><div>A total of 19 spinal TB cases were microbiologically confirmed, out of 58 clinically suspected spinal TB cases, with a male predominance (57.9 %) and age range of 13–72 years. The most common symptom was lower back pain (89.5 %). GeneXpert was positive in all cases, detecting rifampicin resistance in 7(36.8 %). Culture was positive in 11 cases. ZN staining was positive in 15.8 % of direct samples. Histopathology showed granulomatous inflammation in 9 (47.3 %) of cases. MRI confirmed infective spinal involvement in 17(89.5 %) patients. MDR-TB regimen was initiated in 7 patients. Overall recovery was good, except one case of neuropathy and one mortality.</div></div><div><h3>Conclusions</h3><div>A combination of smear microscopy, culture, and molecular diagnostics significantly improves the microbiological diagnosis of spinal TB. GeneXpert offers rapid, reliable results, especially in rifampicin resistance detection. Early and accurate microbiological confirmation, coupled with clinical-radiological correlation, is essential for effective management and improved patient outcomes.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"60 ","pages":"Article 101050"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative evaluation of practical in-vitro methods for testing synergy between ceftazidime-avibactam and aztreonam against metallo-β-lactamase and serine carbapenemase-producing Enterobacterales species 头孢他啶-阿维巴坦和氨曲南对产金属β-内酰胺酶和丝氨酸碳青霉烯酶肠杆菌协同作用的实用体外方法比较评价
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ijmmb.2026.101073
Neha Sunil Bawankar , Samrin Ejaz Hussain Sayed , Swati M. Bhise , Rajni Gaind

Background

The emergence of multidrug-resistant (MDR) strains, including those producing metallo-β-lactamases (MBL), necessitates the development of effective therapeutic strategies. The combination of ceftazidime-avibactam (CZA) and aztreonam (ATM) has shown promise as a potential treatment option. This study aimed to evaluate practical and accessible antimicrobial susceptibility testing (AST) methods for assessing the synergy of CZA and ATM in carbapenemase-producing Enterobacterales species, particularly in resource-limited settings with high patient volumes.

Methods

This cross-sectional study was conducted at a tertiary care hospital in Central India from October 2023 to July 2024. It compared different synergy testing methods to the gold-standard broth microdilution (BMD) method in genotypically confirmed carbapenemase-producing isolates. The study evaluated various synergy methods, such as the E-strip, disk replacement, inverse D-zone, and disk approximation.

Results

Of the 60 Enterobacterales isolates, most carried the blaNDM gene (88.33%, 53/60). Using the BMD method, 73.33% (44/60) of the isolates showed synergy between CZA and ATM. The E-strip method was found to have almost perfect agreement (κ = 1) with BMD, making it highly reliable. However, it may be impractical for high-volume laboratories due to cost and complexity. On the other hand, the disk replacement and inverse D-zone methods demonstrated high sensitivity and specificity, with perfect (κ = 0.874) and substantial (κ = 0.803) agreement with BMD, respectively, providing more practical and cost-effective alternatives. However, the disk approximation method showed lower sensitivity and moderate agreement with BMD (κ = 0.510), making it less reliable.

Conclusion

The combination of CZA and ATM demonstrated significant synergistic results in MBL and serine carbapenemase-producing Enterobacterales species. The disk replacement and inverse D-zone methods are feasible and cost-effective for CZA and ATM synergy testing in routine AST within resource-limited settings, guiding treatment decisions.
背景:多药耐药(MDR)菌株的出现,包括那些产生金属β-内酰胺酶(MBL)的菌株,需要开发有效的治疗策略。头孢他啶-阿维巴坦(CZA)和氨曲南(ATM)的联合治疗已显示出作为一种潜在治疗选择的希望。本研究旨在评估实用和可获得的抗菌药敏试验(AST)方法,以评估CZA和ATM在产碳青霉烯酶肠杆菌物种中的协同作用,特别是在资源有限且患者数量大的环境中。方法:这项横断面研究于2023年10月至2024年7月在印度中部的一家三级保健医院进行。比较了不同协同试验方法与金标准肉汤微量稀释法(BMD)对基因型确证的产碳青霉烯酶分离株的影响。该研究评估了各种协同方法,如E-strip、磁盘替换、逆d区和磁盘近似。结果:60株肠杆菌中大部分携带blaNDM基因(88.33%,53/60)。用BMD方法分析,73.33%(44/60)的菌株CZA与ATM具有协同作用。E-strip法与BMD几乎完全吻合(κ = 1),具有较高的可靠性。然而,由于成本和复杂性,它可能不适合大容量实验室。另一方面,椎间盘置换法和逆d区法表现出较高的敏感性和特异性,与BMD分别具有完美(κ = 0.874)和相当(κ = 0.803)的一致性,提供了更实用、更经济的替代方法。然而,磁盘近似法的灵敏度较低,与BMD的一致性中等(κ = 0.510),可靠性较差。结论:CZA和ATM联合使用对MBL和产丝氨酸碳青霉烯酶肠杆菌具有显著的增效作用。在资源有限的情况下,对于常规AST的CZA和ATM协同测试,磁盘更换和反d区方法是可行且经济有效的,可以指导处理决策。
{"title":"Comparative evaluation of practical in-vitro methods for testing synergy between ceftazidime-avibactam and aztreonam against metallo-β-lactamase and serine carbapenemase-producing Enterobacterales species","authors":"Neha Sunil Bawankar ,&nbsp;Samrin Ejaz Hussain Sayed ,&nbsp;Swati M. Bhise ,&nbsp;Rajni Gaind","doi":"10.1016/j.ijmmb.2026.101073","DOIUrl":"10.1016/j.ijmmb.2026.101073","url":null,"abstract":"<div><h3>Background</h3><div>The emergence of multidrug-resistant (MDR) strains, including those producing metallo-β-lactamases (MBL), necessitates the development of effective therapeutic strategies. The combination of ceftazidime-avibactam (CZA) and aztreonam (ATM) has shown promise as a potential treatment option. This study aimed to evaluate practical and accessible antimicrobial susceptibility testing (AST) methods for assessing the synergy of CZA and ATM in carbapenemase-producing <em>Enterobacterales</em> species, particularly in resource-limited settings with high patient volumes.</div></div><div><h3>Methods</h3><div>This cross-sectional study was conducted at a tertiary care hospital in Central India from October 2023 to July 2024. It compared different synergy testing methods to the gold-standard broth microdilution (BMD) method in genotypically confirmed carbapenemase-producing isolates. The study evaluated various synergy methods, such as the E-strip, disk replacement, inverse D-zone, and disk approximation.</div></div><div><h3>Results</h3><div>Of the 60 <em>Enterobacterales</em> isolates, most carried the <em>bla</em><sub>NDM</sub> gene (88.33%, 53/60). Using the BMD method, 73.33% (44/60) of the isolates showed synergy between CZA and ATM. The E-strip method was found to have almost perfect agreement (κ = 1) with BMD, making it highly reliable. However, it may be impractical for high-volume laboratories due to cost and complexity. On the other hand, the disk replacement and inverse D-zone methods demonstrated high sensitivity and specificity, with perfect (κ = 0.874) and substantial (κ = 0.803) agreement with BMD, respectively, providing more practical and cost-effective alternatives. However, the disk approximation method showed lower sensitivity and moderate agreement with BMD (κ = 0.510), making it less reliable.</div></div><div><h3>Conclusion</h3><div>The combination of CZA and ATM demonstrated significant synergistic results in MBL and serine carbapenemase-producing <em>Enterobacterales</em> species. The disk replacement and inverse D-zone methods are feasible and cost-effective for CZA and ATM synergy testing in routine AST within resource-limited settings, guiding treatment decisions.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"60 ","pages":"Article 101073"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of an enhanced LAMP-based method for early identification of Streptococcus pneumoniae through LytA gene amplification 基于lamp的LytA基因扩增肺炎链球菌早期鉴定方法的建立。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-10 DOI: 10.1016/j.ijmmb.2026.101047
Jignisha S. Patel , Jigna P. Naik , Dhruv N. Desai

Introduction

Streptococcus pneumoniae is a leading cause of invasive bacterial disease in developed and developing countries. The LytA gene acts as a key pneumococcal virulence factor. No simple, cost-effective technology exists to detect this gene. In this study, we developed and validated a quick and visible LAMP assay targeting the LytA gene for pneumococci detection.

Methodology

Visual LAMP assay was performed to amplify the S. pneumoniae LytA gene using five primers. S. pneumoniae ATCC® 49619™ was employed as a positive control, and 19 pathogenic bacterial strains without the LytA gene and 20 clinical isolates with the gene were utilized to test LAMP assay specificity. To assess sensitivity, the visual LAMP assay was compared to PCR using ten-fold serial dilutions of Pneumococcal ATCC DNA. The clinical sensitivity and specificity of the enhanced LAMP assay were tested with 25 pneumonia-suspected clinical samples. In addition, standard microbial culture and PCR analysis were also performed for comparison purposes.

Results

After 60 min of incubation at 65 °C, the S. pneumoniae ATCC strain and all 20 clinical pneumococci with defined primers amplified LytA target DNA and gave a color change from pink to yellow. DNA amplification was absent in 19 pathogenic bacterial strains without LytA genes under the same circumstances. The detection limit for the improved LAMP assay was 6 CFU/mL (0.425 fg/μL). Given conventional microbiological culture as the gold standard, the PCR assay provided two false positives, whereas the LAMP assay gave no false positives with 25 clinical samples. The LAMP assay exhibited 100 % sensitivity, specificity, PPV and NPV (95 % CI) utilizing the conventional culture method as a gold standard.

Conclusion

The enhanced LAMP assay visually detects the pneumococcal LytA gene faster, simpler, more sensitively, and more specifically than PCR and microbiological methods. This enhanced LAMP method is suited for low-resource population screening and diagnosis.
简介:肺炎链球菌是发达国家和发展中国家侵袭性细菌疾病的主要原因。LytA基因是一个关键的肺炎球菌毒力因子。目前还没有一种简单、经济的技术来检测这种基因。在这项研究中,我们开发并验证了一种针对LytA基因的快速可见LAMP检测方法,用于肺炎球菌的检测。方法:采用LAMP法,用5个引物扩增肺炎链球菌LytA基因。以肺炎链球菌ATCC®49619™为阳性对照,选取19株不含LytA基因的病原菌和20株含LytA基因的临床分离菌进行LAMP特异性检测。为了评估灵敏度,使用肺炎球菌ATCC DNA的10倍连续稀释,将目视LAMP试验与PCR进行比较。应用增强型LAMP检测方法对25例疑似肺炎临床标本进行临床敏感性和特异性检测。此外,还进行了标准微生物培养和PCR分析以进行比较。结果:在65℃下培养60分钟后,肺炎链球菌ATCC菌株和所有20种临床肺炎球菌均扩增出LytA靶DNA,颜色由粉红色变为黄色。在相同条件下,19株不含LytA基因的病原菌没有DNA扩增。改进LAMP法的检出限为6 CFU/mL (0.425 fg/μL)。以传统微生物培养为金标准,PCR检测出现2个假阳性,而LAMP检测在25个临床样本中没有出现假阳性。LAMP检测具有100%的灵敏度、特异性、PPV和NPV (95% CI),以常规培养方法为金标准。结论:增强型LAMP法检测肺炎球菌LytA基因比PCR和微生物学方法更快、更简单、更敏感、更特异。这种增强型LAMP方法适用于低资源人群的筛查和诊断。
{"title":"Development of an enhanced LAMP-based method for early identification of Streptococcus pneumoniae through LytA gene amplification","authors":"Jignisha S. Patel ,&nbsp;Jigna P. Naik ,&nbsp;Dhruv N. Desai","doi":"10.1016/j.ijmmb.2026.101047","DOIUrl":"10.1016/j.ijmmb.2026.101047","url":null,"abstract":"<div><h3>Introduction</h3><div><em>Streptococcus pneumoniae</em> is a leading cause of invasive bacterial disease in developed and developing countries. The <em>Lyt</em>A gene acts as a key pneumococcal virulence factor. No simple, cost-effective technology exists to detect this gene. In this study, we developed and validated a quick and visible LAMP assay targeting the <em>Lyt</em>A gene for pneumococci detection.</div></div><div><h3>Methodology</h3><div>Visual LAMP assay was performed to amplify the <em>S. pneumoniae Lyt</em>A gene using five primers. <em>S. pneumoniae</em> ATCC® 49619™ was employed as a positive control, and 19 pathogenic bacterial strains without the <em>Lyt</em>A gene and 20 clinical isolates with the gene were utilized to test LAMP assay specificity. To assess sensitivity, the visual LAMP assay was compared to PCR using ten-fold serial dilutions of Pneumococcal ATCC DNA. The clinical sensitivity and specificity of the enhanced LAMP assay were tested with 25 pneumonia-suspected clinical samples. In addition, standard microbial culture and PCR analysis were also performed for comparison purposes.</div></div><div><h3>Results</h3><div>After 60 min of incubation at 65 °C, the <em>S. pneumoniae</em> ATCC strain and all 20 clinical pneumococci with defined primers amplified <em>Lyt</em>A target DNA and gave a color change from pink to yellow. DNA amplification was absent in 19 pathogenic bacterial strains without <em>Lyt</em>A genes under the same circumstances. The detection limit for the improved LAMP assay was 6 CFU/mL (0.425 fg/μL). Given conventional microbiological culture as the gold standard, the PCR assay provided two false positives, whereas the LAMP assay gave no false positives with 25 clinical samples. The LAMP assay exhibited 100 % sensitivity, specificity, PPV and NPV (95 % CI) utilizing the conventional culture method as a gold standard.</div></div><div><h3>Conclusion</h3><div>The enhanced LAMP assay visually detects the pneumococcal <em>Lyt</em>A gene faster, simpler, more sensitively, and more specifically than PCR and microbiological methods. This enhanced LAMP method is suited for low-resource population screening and diagnosis.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"60 ","pages":"Article 101047"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145959240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy of urinary lipoarabinomannan antigen detection for the diagnosis of pulmonary and extra pulmonary tuberculosis (EPTB) in HIV negative population 尿脂arabinman聚糖抗原检测对HIV阴性人群肺结核和肺外结核(EPTB)诊断的准确性
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-22 DOI: 10.1016/j.ijmmb.2026.101053
Kiran Bala , Rekha Rathee , Prayas Sethi , Praveen Bharti , Bhavuk Garg , Anant Mohan , Urvashi B. Singh

Background

Urine antigen testing seems promising tool to detect tuberculosis but data is scarce for pulmonary and extrapulmonary tuberculosis in HIV negative population.

Aims

This prospective cross-sectional study was designed to assess the urinary lipoarabinomannan antigen (LAM) diagnostic accuracy of pulmonary and extrapulmonary tuberculosis in HIV negative population.

Materials & methods

Suspected pulmonary (PTB) and extrapulmonary tuberculosis (EPTB) patients were enrolled and samples were subjected to routine diagnostic modalities. Urine samples were subjected to LAM test using lateral flow assay of Abbott TB LAM & results were statistically evaluated to gold standard culture, microbiological reference standards (MRS).

Results

Total 224 patients of suspected tuberculosis were enrolled in the study (23.21 % PTB and 76.79 % EPTB). Microbiologically confirmed tuberculosis was detected in 44 (19.6 %), PTB (48.0 %) & EPTB (11.0 %) cases. Mycobacterium tuberculosis was detected in ZN stain (16.5 %), MGIT liquid culture (14.7 %), Gene-Xpert MTB/Rif (17.4 %), urinary LAM (22.7 %). Sensitivity, specificity, PPV and NPV of urine LAM against the gold standard test (MGIT) were 60.61 %, 83.77 %, 39.22 %, 92.49 %; and as per the MRS criteria these values were 48.0 %, 84.5 %, 47.1 %, 85.0 % respectively. Among smear positive samples sensitivity, specificity, PPV, NPV of LAM were 65.5 %, 50.0 %, 82.6 %, 28.6 % respectively.

Conclusion

Urine LAM performed better than previously reported in HIV-negative populations but remains suboptimal as a point-of-care test. This study showed higher sensitivity and PPV for pulmonary TB in MRS smear-positive cases, better specificity and NPV for extrapulmonary TB, good performance in smear-negative extrapulmonary TB, and promising utility in unconfirmed TB.
背景:在HIV阴性人群中,尿液抗原检测似乎是一种很有前途的检测结核病的工具,但关于肺结核和肺外结核的数据很少。目的:本前瞻性横断研究旨在评估尿脂阿拉伯糖甘露聚糖抗原(LAM)对HIV阴性人群肺结核和肺外结核的诊断准确性。材料与方法对疑似肺结核(PTB)和肺外结核(EPTB)患者进行常规诊断。尿液样本采用雅培TB LAM横向流动法进行LAM检测,结果统计评估为金标准培养,微生物参考标准(MRS)。结果共纳入疑似结核患者224例,其中肺结核占23.21%,EPTB占76.79%。微生物学确诊结核44例(19.6%),肺结核(48.0%)和EPTB(11.0%)。ZN染色检出结核分枝杆菌(16.5%),MGIT液体培养(14.7%),Gene-Xpert MTB/Rif(17.4%),尿LAM(22.7%)检出结核分枝杆菌。尿液LAM对金标准试验(MGIT)的敏感性、特异性、PPV和NPV分别为60.61%、83.77%、39.22%、92.49%;按MRS标准分别为48.0%、84.5%、47.1%、85.0%。在涂片阳性样本中,LAM的敏感性为65.5%,特异性为50.0%,PPV为82.6%,NPV为28.6%。结论尿液LAM在hiv阴性人群中的表现比之前报道的要好,但作为一种即时检测方法仍然不够理想。该研究显示,MRS涂片阳性病例对肺结核具有更高的敏感性和PPV,对肺外结核具有更好的特异性和NPV,对涂片阴性的肺外结核具有良好的疗效,对未确诊结核病具有良好的应用前景。
{"title":"Diagnostic accuracy of urinary lipoarabinomannan antigen detection for the diagnosis of pulmonary and extra pulmonary tuberculosis (EPTB) in HIV negative population","authors":"Kiran Bala ,&nbsp;Rekha Rathee ,&nbsp;Prayas Sethi ,&nbsp;Praveen Bharti ,&nbsp;Bhavuk Garg ,&nbsp;Anant Mohan ,&nbsp;Urvashi B. Singh","doi":"10.1016/j.ijmmb.2026.101053","DOIUrl":"10.1016/j.ijmmb.2026.101053","url":null,"abstract":"<div><h3>Background</h3><div>Urine antigen testing seems promising tool to detect tuberculosis but data is scarce for pulmonary and extrapulmonary tuberculosis in HIV negative population.</div></div><div><h3>Aims</h3><div>This prospective cross-sectional study was designed to assess the urinary lipoarabinomannan antigen (LAM) diagnostic accuracy of pulmonary and extrapulmonary tuberculosis in HIV negative population.</div></div><div><h3>Materials &amp; methods</h3><div>Suspected pulmonary (PTB) and extrapulmonary tuberculosis (EPTB) patients were enrolled and samples were subjected to routine diagnostic modalities. Urine samples were subjected to LAM test using lateral flow assay of Abbott TB LAM &amp; results were statistically evaluated to gold standard culture, microbiological reference standards (MRS).</div></div><div><h3>Results</h3><div>Total 224 patients of suspected tuberculosis were enrolled in the study (23.21 % PTB and 76.79 % EPTB). Microbiologically confirmed tuberculosis was detected in 44 (19.6 %), PTB (48.0 %) &amp; EPTB (11.0 %) cases. <em>Mycobacterium tuberculosis</em> was detected in ZN stain (16.5 %), MGIT liquid culture (14.7 %), Gene-Xpert MTB/Rif (17.4 %), urinary LAM (22.7 %). Sensitivity, specificity, PPV and NPV of urine LAM against the gold standard test (MGIT) were 60.61 %, 83.77 %, 39.22 %, 92.49 %; and as per the MRS criteria these values were 48.0 %, 84.5 %, 47.1 %, 85.0 % respectively. Among smear positive samples sensitivity, specificity, PPV, NPV of LAM were 65.5 %, 50.0 %, 82.6 %, 28.6 % respectively.</div></div><div><h3>Conclusion</h3><div>Urine LAM performed better than previously reported in HIV-negative populations but remains suboptimal as a point-of-care test. This study showed higher sensitivity and PPV for pulmonary TB in MRS smear-positive cases, better specificity and NPV for extrapulmonary TB, good performance in smear-negative extrapulmonary TB, and promising utility in unconfirmed TB.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"60 ","pages":"Article 101053"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146035753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the drug prescribing pattern in a tertiary care trauma centre outpatient department in North India: A cross-sectional study 评估北印度三级护理创伤中心门诊的药物处方模式:一项横断面研究。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-16 DOI: 10.1016/j.ijmmb.2026.101080
Madhumitha Balasubramanian , Projoyita Samanta , Parul Singh , Sushma Sagar , Subodh Kumar , Deepak Gupta , Kamran Farooque , Vijay Sharma , Vivek Trikha , Purva Mathur

Purpose

There is a need for rational prescribing of drugs to achieve healthcare outcomes. One of the major consequences of irrational drug use is the emergence of antibiotic resistance. Therefore, drug prescribing practices must be scrutinized at regular intervals to ensure patient safety. In this study, we aimed to evaluate the prescribing pattern of physicians using the ‘WHO-recommended core prescribing indicators’ in the OPD of a tertiary care trauma centre in North India.

Materials and methods

This was a prospective, cross-sectional study conducted at all the outpatient departments of a tertiary care trauma centre hospital for a period of 3 months from February to May 2024. A total of 822 prescriptions were assessed based on the World Health Organization (WHO) core prescribing indicators according to guidelines and methods for data consistency. Descriptive statistical analyses (frequencies, mean, percentages, and standard deviation) were used to report the data.

Results

The WHO core prescribing indicators analysis showed that the average number of drugs per encounter was 1.25, 47.47% of the drugs were prescribed by generic name, and duration was mentioned only for 55.04% drugs. The percentage of antibiotics prescribed per encounter was 4.86% which was much lower than the ideal WHO recommendations. The most frequently prescribed antibiotic was Cefuroxime, which belongs to WATCH group according to AWaRe classification list, and only 53.68% (n = 553) of the drugs were from the National List of Essential Medicines.

Conclusion

The present study on audit of prescription practices was performed using ‘WHO core prescribing indicators, highlights adherence to rationality and completeness. Improvement is needed in generic prescribing and completeness of prescriptions. Regular audits and AWaRe-based practices could enhance rational, cost-effective healthcare delivery.
目的:需要合理的处方药物,以实现卫生保健结果。不合理用药的主要后果之一是抗生素耐药性的出现。因此,必须定期审查药物处方,以确保患者的安全。在这项研究中,我们的目的是评估医生使用“世卫组织推荐的核心处方指标”在印度北部三级护理创伤中心的门诊开处方模式。材料和方法:这是一项前瞻性横断面研究,于2024年2月至5月在一家三级护理创伤中心医院的所有门诊进行,为期3个月。根据数据一致性指南和方法,根据世界卫生组织(世卫组织)核心处方指标对总共822种处方进行了评估。描述性统计分析(频率、平均值、百分比和标准差)用于报告数据。结果:WHO核心处方指标分析显示,平均每次就诊药品数量为1.25种,47.47%的药品以通用名开具处方,只有55.04%的药品提及了用药时间。每次就诊处方抗生素的百分比为4.86%,远低于世卫组织的理想建议。使用频次最高的抗生素是头孢呋辛,根据AWaRe分类目录属于WATCH类,仅有53.68% (n=553)的药物来自《国家基本药物目录》。结论:本研究采用WHO核心处方指标对处方操作进行审核,突出了对合理性和完整性的坚持。处方的通用性和处方的完整性有待改进。定期审计和基于意识的实践可以增强合理的、具有成本效益的医疗保健服务。
{"title":"Evaluating the drug prescribing pattern in a tertiary care trauma centre outpatient department in North India: A cross-sectional study","authors":"Madhumitha Balasubramanian ,&nbsp;Projoyita Samanta ,&nbsp;Parul Singh ,&nbsp;Sushma Sagar ,&nbsp;Subodh Kumar ,&nbsp;Deepak Gupta ,&nbsp;Kamran Farooque ,&nbsp;Vijay Sharma ,&nbsp;Vivek Trikha ,&nbsp;Purva Mathur","doi":"10.1016/j.ijmmb.2026.101080","DOIUrl":"10.1016/j.ijmmb.2026.101080","url":null,"abstract":"<div><h3>Purpose</h3><div>There is a need for rational prescribing of drugs to achieve healthcare outcomes. One of the major consequences of irrational drug use is the emergence of antibiotic resistance. Therefore, drug prescribing practices must be scrutinized at regular intervals to ensure patient safety. In this study, we aimed to evaluate the prescribing pattern of physicians using the ‘WHO-recommended core prescribing indicators’ in the OPD of a tertiary care trauma centre in North India.</div></div><div><h3>Materials and methods</h3><div>This was a prospective, cross-sectional study conducted at all the outpatient departments of a tertiary care trauma centre hospital for a period of 3 months from February to May 2024. A total of 822 prescriptions were assessed based on the World Health Organization (WHO) core prescribing indicators according to guidelines and methods for data consistency. Descriptive statistical analyses (frequencies, mean, percentages, and standard deviation) were used to report the data.</div></div><div><h3>Results</h3><div>The WHO core prescribing indicators analysis showed that the average number of drugs per encounter was 1.25, 47.47% of the drugs were prescribed by generic name, and duration was mentioned only for 55.04% drugs. The percentage of antibiotics prescribed per encounter was 4.86% which was much lower than the ideal WHO recommendations. The most frequently prescribed antibiotic was Cefuroxime, which belongs to WATCH group according to AWaRe classification list, and only 53.68% (n = 553) of the drugs were from the National List of Essential Medicines.</div></div><div><h3>Conclusion</h3><div>The present study on audit of prescription practices was performed using ‘WHO core prescribing indicators, highlights adherence to rationality and completeness. Improvement is needed in generic prescribing and completeness of prescriptions. Regular audits and AWaRe-based practices could enhance rational, cost-effective healthcare delivery.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"60 ","pages":"Article 101080"},"PeriodicalIF":1.3,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146219429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent MALDI-TOF MS identification failure for Sphingomonas paucimobilis from blood cultures: A single-center observation 血液培养中反复MALDI-TOF质谱鉴定少动鞘氨单胞菌失败:单中心观察。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-11 DOI: 10.1016/j.ijmmb.2025.101009
Shikhir Malhotra, Vibhor Tak
{"title":"Recurrent MALDI-TOF MS identification failure for Sphingomonas paucimobilis from blood cultures: A single-center observation","authors":"Shikhir Malhotra,&nbsp;Vibhor Tak","doi":"10.1016/j.ijmmb.2025.101009","DOIUrl":"10.1016/j.ijmmb.2025.101009","url":null,"abstract":"","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101009"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis of the diagnostic value of polymerase chain reaction-based nucleic acid detection methods for pertussis 聚合酶链反应核酸检测方法对百日咳诊断价值的meta分析
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-24 DOI: 10.1016/j.ijmmb.2025.101031
Fengyuan He , Limin Mei , Linzi Zeng

Introduction

Pertussis is an acute respiratory disease primarily caused by Bordetella pertussis, and its incidence has shown a resurgence. Polymerase chain reaction (PCR) is a recognized molecular detection method, and various related detection methods have emerged.

Methods

This study is performed according to the PRISMA checklist. Relevant literature is adopted from the online databases. The quality of the included studies is assessed based on the REVMAN software (version 5.4). Statistical analysis is performed by STATA 14.0 and Meta-DiSc 1.4 software.

Results

The results of this meta-analysis show that four different PCR techniques—conventional PCR, real-time quantitative PCR (Q-PCR), multiplex PCR, and nested PCR—have a pooled sensitivity of 0.95 (95 % CI: 0.93–0.97), pooled specificity of 0.93 (95 % CI: 0.89–0.95), pooled positive likelihood ratio (PLR) of 12.22 (95 % CI: 8.62–17.33), pooled negative likelihood ratio (NLR) of 0.05 (95 % CI: 0.03–0.08), and pooled diagnostic odds ratio (DOR) of 244.88 (95 % CI: 133.34–449.72). Multiplex PCR has the highest pooled specificity, PLR, and DOR. Nested PCR has the highest sensitivity and the lowest NLR. PCR testing holds significant value in the early diagnosis of pertussis. Multiplex PCR, nested PCR, and Q-PCR outperform conventional PCR in diagnostic performance.

Conclusions

Each type of PCR test has its advantages and disadvantages, and clinical selection should consider factors such as testing purpose, personnel, and conditions.
简介百日咳是一种主要由百日咳博德泰拉引起的急性呼吸道疾病,其发病率呈死灰复燃趋势。聚合酶链反应(Polymerase chain reaction, PCR)是一种公认的分子检测方法,相关的检测方法层出不穷。方法本研究按照PRISMA检查表进行。相关文献采用在线数据库。采用REVMAN软件(版本5.4)评估纳入研究的质量。采用STATA 14.0和Meta-DiSc 1.4软件进行统计分析。结果常规PCR、实时定量PCR (Q-PCR)、多重PCR和巢式PCR 4种不同PCR技术的合并敏感性为0.95 (95% CI: 0.93 ~ 0.97),合并特异性为0.93 (95% CI: 0.89 ~ 0.95),合并阳性似然比(PLR)为12.22 (95% CI: 8.62 ~ 17.33),合并阴性似然比(NLR)为0.05 (95% CI: 0.03 ~ 0.08),合并诊断优势比(DOR)为244.88 (95% CI: 133.34 ~ 449.72)。多重PCR具有最高的聚合特异性、PLR和DOR。巢式PCR的灵敏度最高,NLR最低。PCR检测对百日咳的早期诊断有重要价值。多重PCR、巢式PCR和Q-PCR在诊断性能上优于传统PCR。结论每种PCR检测方法各有优缺点,临床应综合考虑检测目的、人员、条件等因素进行选择。
{"title":"Meta-analysis of the diagnostic value of polymerase chain reaction-based nucleic acid detection methods for pertussis","authors":"Fengyuan He ,&nbsp;Limin Mei ,&nbsp;Linzi Zeng","doi":"10.1016/j.ijmmb.2025.101031","DOIUrl":"10.1016/j.ijmmb.2025.101031","url":null,"abstract":"<div><h3>Introduction</h3><div>Pertussis is an acute respiratory disease primarily caused by <em>Bordetella pertussis</em>, and its incidence has shown a resurgence. Polymerase chain reaction (PCR) is a recognized molecular detection method, and various related detection methods have emerged.</div></div><div><h3>Methods</h3><div>This study is performed according to the PRISMA checklist. Relevant literature is adopted from the online databases. The quality of the included studies is assessed based on the REVMAN software (version 5.4). Statistical analysis is performed by STATA 14.0 and Meta-DiSc 1.4 software.</div></div><div><h3>Results</h3><div>The results of this meta-analysis show that four different PCR techniques—conventional PCR, real-time quantitative PCR (Q-PCR), multiplex PCR, and nested PCR—have a pooled sensitivity of 0.95 (95 % CI: 0.93–0.97), pooled specificity of 0.93 (95 % CI: 0.89–0.95), pooled positive likelihood ratio (PLR) of 12.22 (95 % CI: 8.62–17.33), pooled negative likelihood ratio (NLR) of 0.05 (95 % CI: 0.03–0.08), and pooled diagnostic odds ratio (DOR) of 244.88 (95 % CI: 133.34–449.72). Multiplex PCR has the highest pooled specificity, PLR, and DOR. Nested PCR has the highest sensitivity and the lowest NLR. PCR testing holds significant value in the early diagnosis of pertussis. Multiplex PCR, nested PCR, and Q-PCR outperform conventional PCR in diagnostic performance.</div></div><div><h3>Conclusions</h3><div>Each type of PCR test has its advantages and disadvantages, and clinical selection should consider factors such as testing purpose, personnel, and conditions.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101031"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145621855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Scarlet fever - A retrospective case series in the midst of recent upsurge of cases in India 猩红热——印度最近病例激增期间的回顾性病例系列。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-15 DOI: 10.1016/j.ijmmb.2025.101040
K. Dhanalakshmi, S. Balasubramanian, N. Vignesh, S. Mahalakshmi, Sulochana Putili Bai
Scarlet fever, caused by Group A Streptococcus [Streptococcus pyogenes], presents with a characteristic red rash, fever, and pharyngitis. It predominantly affects children aged 5–15 years, although individuals of any age can be affected. Transmission occurs via respiratory droplets and direct contact with contaminated surfaces or infected individuals. This study emphasizes the utility of rapid antigen detection tests [RADT] as point-of-care diagnostics for scarlet fever, particularly in the context of the recent rise in cases in India. Early diagnosis and initiation of appropriate antibiotic therapy are critical to preventing complications such as acute rheumatic fever and renal involvement.
猩红热是由A群链球菌(化脓性链球菌)引起的,表现为典型的红疹、发热和咽炎。它主要影响5-15岁的儿童,尽管任何年龄的人都可能受到影响。传播途径为呼吸道飞沫和直接接触污染表面或受感染个体。这项研究强调了快速抗原检测试验(RADT)作为猩红热即时诊断的效用,特别是在最近印度病例上升的背景下。早期诊断和开始适当的抗生素治疗对于预防急性风湿热和肾脏受累等并发症至关重要。
{"title":"Scarlet fever - A retrospective case series in the midst of recent upsurge of cases in India","authors":"K. Dhanalakshmi,&nbsp;S. Balasubramanian,&nbsp;N. Vignesh,&nbsp;S. Mahalakshmi,&nbsp;Sulochana Putili Bai","doi":"10.1016/j.ijmmb.2025.101040","DOIUrl":"10.1016/j.ijmmb.2025.101040","url":null,"abstract":"<div><div>Scarlet fever, caused by <em>Group A Streptococcus</em> [<em>Streptococcus pyogenes</em>], presents with a characteristic red rash, fever, and pharyngitis. It predominantly affects children aged 5–15 years, although individuals of any age can be affected. Transmission occurs via respiratory droplets and direct contact with contaminated surfaces or infected individuals. This study emphasizes the utility of rapid antigen detection tests [RADT] as point-of-care diagnostics for scarlet fever, particularly in the context of the recent rise in cases in India. Early diagnosis and initiation of appropriate antibiotic therapy are critical to preventing complications such as acute rheumatic fever and renal involvement.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101040"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145774205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular epidemiology of human rhinovirus from clinical cases of Dibrugarh, Assam, India 印度阿萨姆邦迪布鲁加尔邦临床病例中人鼻病毒的分子流行病学研究
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-21 DOI: 10.1016/j.ijmmb.2025.101027
Mandakini Das , Biswajyoti Borkakoty , Nargis K. Bali , Neelanjana Sarmah , Aniruddha Jakharia , Rahul Hazarika , Chandrakanta Bhattacharya , Aktarul Islam Siddique , Kishore Sarma , Kimmi Sarmah , Harpreet Kaur

Purpose

Human rhinovirus (HRV), a member of the Enterovirus genus of the Picornaviridae family is a major respiratory pathogen and the leading cause of upper respiratory tract infections. Given the limited information on HRV prevalence and molecular epidemiology in Northeast India, this study investigated circulating HRV strains in the region from 2015 to 2018.

Methods

Nasopharyngeal and throat swab samples were collected and RNA was extracted for HRV detection using qRT-PCR. HRV-positive samples were subjected to bidirectional Sanger sequencing targeting the 549 bp VP4/VP2 region. Obtained sequences were aligned and analyzed phylogenetically using bioinformatics tools to determine genotype distribution and genetic diversity.

Results

Among 2642 cases, 354 (13.3 %) tested positive for HRV. HRV-C was the predominant species (48.7 %), followed by HRV-A (38.4 %) and HRV-B (7.6 %). HRV infection was significantly associated with lower respiratory symptoms such as cough (p < 0.001) and breathlessness (p < 0.026). The study identified 27 different HRV genotypes in the 39 sequenced samples, with HRV-C15 being the most common (9/39) overall and associated with disease severity (p = 0.003). Seasonality analysis indicated peak HRV circulation between August and November (48.8 %, 173/354), with the lowest detected in June–July (14.1 %). HRV-C was more frequently observed in severe acute respiratory infection (SARI) cases and demonstrated the highest heterogeneity, with an intra-species nucleotide mean p-distance of 24.0 %.

Conclusion

In conclusion, this study presents the first report on the prevalence of human rhinovirus (HRV) among influenza-like illness (ILI) cases in Dibrugarh, Assam, India. HRV-C exhibited distinct epidemiological characteristics compared to HRV-A and HRV-B strains. Molecular epidemiological analysis revealed notable nucleotide variation in the VP4/VP2 region, with HRV-C15 emerging as the predominant genotype associated with increased disease severity. Further research involving larger sample sizes and detailed clinical follow-up is essential to better understand the genotype distribution and genetic diversity of HRV strains circulating in the region.
目的:人鼻病毒(HRV)是小核糖核酸病毒科肠病毒属的一员,是一种主要的呼吸道病原体,是上呼吸道感染的主要原因。鉴于印度东北部HRV患病率和分子流行病学信息有限,本研究调查了2015年至2018年该地区流行的HRV菌株。方法:采集鼻咽和咽拭子标本,提取RNA,采用qRT-PCR检测HRV。hrv阳性样本针对549 bp VP4/VP2区域进行双向Sanger测序。利用生物信息学工具对获得的序列进行比对和系统发育分析,以确定基因型分布和遗传多样性。结果:2642例中,HRV阳性354例(13.3%)。HRV-C是优势种(48.7%),其次是HRV-A(38.4%)和HRV-B(7.6%)。HRV感染与咳嗽等下呼吸道症状显著相关(结论:本研究首次报道了印度阿萨姆邦迪布鲁加尔省流感样疾病(ILI)病例中人鼻病毒(HRV)的流行情况。与HRV-A和HRV-B株相比,HRV-C株具有明显的流行病学特征。分子流行病学分析显示VP2/VP4区域的核苷酸显著变异,HRV-C15成为与疾病严重程度增加相关的主要基因型。为了更好地了解该地区流行的HRV毒株的基因型分布和遗传多样性,需要开展更大样本量和详细临床随访的进一步研究。
{"title":"Molecular epidemiology of human rhinovirus from clinical cases of Dibrugarh, Assam, India","authors":"Mandakini Das ,&nbsp;Biswajyoti Borkakoty ,&nbsp;Nargis K. Bali ,&nbsp;Neelanjana Sarmah ,&nbsp;Aniruddha Jakharia ,&nbsp;Rahul Hazarika ,&nbsp;Chandrakanta Bhattacharya ,&nbsp;Aktarul Islam Siddique ,&nbsp;Kishore Sarma ,&nbsp;Kimmi Sarmah ,&nbsp;Harpreet Kaur","doi":"10.1016/j.ijmmb.2025.101027","DOIUrl":"10.1016/j.ijmmb.2025.101027","url":null,"abstract":"<div><h3>Purpose</h3><div>Human rhinovirus (HRV), a member of the <em>Enterovirus</em> genus of the <em>Picornaviridae</em> family is a major respiratory pathogen and the leading cause of upper respiratory tract infections. Given the limited information on HRV prevalence and molecular epidemiology in Northeast India, this study investigated circulating HRV strains in the region from 2015 to 2018.</div></div><div><h3>Methods</h3><div>Nasopharyngeal and throat swab samples were collected and RNA was extracted for HRV detection using qRT-PCR. HRV-positive samples were subjected to bidirectional Sanger sequencing targeting the 549 bp VP4/VP2 region. Obtained sequences were aligned and analyzed phylogenetically using bioinformatics tools to determine genotype distribution and genetic diversity.</div></div><div><h3>Results</h3><div>Among 2642 cases, 354 (13.3 %) tested positive for HRV. HRV-C was the predominant species (48.7 %), followed by HRV-A (38.4 %) and HRV-B (7.6 %). HRV infection was significantly associated with lower respiratory symptoms such as cough (p &lt; 0.001) and breathlessness (p &lt; 0.026). The study identified 27 different HRV genotypes in the 39 sequenced samples, with HRV-C15 being the most common (9/39) overall and associated with disease severity (p = 0.003). Seasonality analysis indicated peak HRV circulation between August and November (48.8 %, 173/354), with the lowest detected in June–July (14.1 %). HRV-C was more frequently observed in severe acute respiratory infection (SARI) cases and demonstrated the highest heterogeneity, with an intra-species nucleotide mean p-distance of 24.0 %.</div></div><div><h3>Conclusion</h3><div>In conclusion, this study presents the first report on the prevalence of human rhinovirus (HRV) among influenza-like illness (ILI) cases in Dibrugarh, Assam, India. HRV-C exhibited distinct epidemiological characteristics compared to HRV-A and HRV-B strains. Molecular epidemiological analysis revealed notable nucleotide variation in the VP4/VP2 region, with HRV-C15 emerging as the predominant genotype associated with increased disease severity. Further research involving larger sample sizes and detailed clinical follow-up is essential to better understand the genotype distribution and genetic diversity of HRV strains circulating in the region.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101027"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145587306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Out of Sight, Should not be out of mind: A perplexing case of Malaria 眼不见,心不应忘:一个令人困惑的疟疾病例。
IF 1.3 4区 医学 Q4 IMMUNOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-21 DOI: 10.1016/j.ijmmb.2025.101028
Shilpi Saxena , Reena Das , Sumeeta Khurana , Saleem Amjad Mirza , Kamal Deep Joshi , Harleen Kaur
Malaria diagnosis is often difficult in cases with low parasitaemia and atypical presentations. We report a 30-year-old male with high-grade fever, chills, and vomiting. At admission, he was afebrile, pale, and had progressive splenomegaly. Despite extensive investigations, including multiple peripheral blood smears and malaria rapid diagnostic tests, results were negative. Bone marrow examination revealed rare red blood cells with Plasmodium spp., confirmed by PCR from the marrow aspirate slide. He completely recovered after treatment with Artemether-Lumefantrine and Primaquine. This case underscores the value of bone marrow microscopy and PCR in diagnosing malaria in patients with unexplained cytopenias and splenomegaly.
在低寄生虫血症和非典型表现的病例中,疟疾诊断往往很困难。我们报告一名30岁男性患者出现高热、寒战和呕吐。入院时,他发热,脸色苍白,并有进行性脾大。尽管进行了广泛的调查,包括多次外周血涂片和疟疾快速诊断测试,但结果均为阴性。骨髓检查发现罕见的带有疟原虫的红细胞,经骨髓吸片PCR证实。经甲醚-氨苯曲明和伯氨喹治疗后完全康复。本病例强调了骨髓显微镜和PCR在诊断不明原因的细胞减少和脾肿大患者的疟疾中的价值。
{"title":"Out of Sight, Should not be out of mind: A perplexing case of Malaria","authors":"Shilpi Saxena ,&nbsp;Reena Das ,&nbsp;Sumeeta Khurana ,&nbsp;Saleem Amjad Mirza ,&nbsp;Kamal Deep Joshi ,&nbsp;Harleen Kaur","doi":"10.1016/j.ijmmb.2025.101028","DOIUrl":"10.1016/j.ijmmb.2025.101028","url":null,"abstract":"<div><div>Malaria diagnosis is often difficult in cases with low parasitaemia and atypical presentations. We report a 30-year-old male with high-grade fever, chills, and vomiting. At admission, he was afebrile, pale, and had progressive splenomegaly. Despite extensive investigations, including multiple peripheral blood smears and malaria rapid diagnostic tests, results were negative. Bone marrow examination revealed rare red blood cells with <em>Plasmodium</em> spp., confirmed by PCR from the marrow aspirate slide. He completely recovered after treatment with Artemether-Lumefantrine and Primaquine. This case underscores the value of bone marrow microscopy and PCR in diagnosing malaria in patients with unexplained cytopenias and splenomegaly.</div></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"59 ","pages":"Article 101028"},"PeriodicalIF":1.3,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145587349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Medical Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1